
Shedding Light on AK Management with PDT
Photodynamic therapy (PDT) remains an important treatment option for actinic keratosis (AK), offering a field-directed approach that can address both clinical and subclinical disease. In this expert panel discussion, leading Canadian dermatologists will review the evolving role and benefits of PDT in AK management. Attendees will gain an early look at key recommendations from the newly published Canadian PDT consensus paper developed by national experts to support best practices in clinical care and explore emerging evidence and unmet needs in post-PDT patient care.
- Review the role of photodynamic therapy (PDT) and its benefits in the management of actinic keratosis (AK), highlighting patient selection considerations, and real-world practice experience
- Discuss key recommendations from the new Canadian PDT consensus paper, including best practices aimed at optimizing treatment outcomes and standardizing PDT use across clinical settings
- Explore emerging evidence and unmet needs in post-PDT patient care
